LBV is a technology company.
LBV has raised $100.0M across 1 funding round.
LBV has raised $100.0M in total across 1 funding round.
LBV Ventures (LBV) is a boutique consultancy firm focused on venture strategy, acceleration, and business development, led by Founder and CEO Luis Barros.[1] It specializes in supporting venture capital-backed entrepreneurship through strategic consulting, de-risking methodologies, and fostering partnerships across public and private sectors, with expertise in areas like neurotechnology, mental health, diagnostics, data analytics, and image processing.[1] The firm combines marketing, financial services, and business model optimization to enhance marketplace readiness and enable strategic alliances, drawing on a network of experts including Managing Director Patterson Shafer from FTI Consulting, who brings over 30 years in health solutions, regulatory affairs, and AI/machine learning for life sciences.[1]
Note that multiple entities share the "LBV" name, including LBV Technology Services Limited (a UK company incorporated in March 2024 in Hungerford, Berkshire)[2][6] and LBV Consulting Services LLC (technology services for banking and healthcare).[3] However, the most detailed match to a technology-oriented consultancy is LBV Ventures.[1] It is not an investment firm or traditional startup but aids startups via consulting and venturing capital teams.
LBV Ventures was founded by Luis Barros, who serves as CEO, establishing it as a specialized consultancy in venture strategy and acceleration.[1] The firm's network includes key figures like Anthony (with degrees in Electrical and Biomedical Engineering, a PhD from Rutgers, and an MBA from MIT Sloan), focusing on technologies in neurotech, mental health, and data analytics, and Patterson Shafer, a veteran in pharmaceutical and biotech consulting.[1] It evolved to emphasize international venturing capital teams that bridge venture-backed programs with innovation clusters for economic impact, alongside management consulting for de-risking startups.[1]
Limited public details exist on exact founding year, but the firm's structure highlights collaborations with experienced professionals in business-technology intersections, such as regulatory systems and AI for life sciences.[1] Other LBV entities, like LBV Technology Services Limited, are very recent (incorporated March 14, 2024).[2][6]
LBV rides trends in health tech and biotech innovation, particularly at the "intersection of business and technology" like AI/machine learning for regulatory systems, digital health, and patient safety—areas accelerated by post-pandemic demands for faster market entry and compliance.[1] Timing favors LBV amid global life sciences growth, where emerging companies need de-risking to scale amid regulatory hurdles from bodies like the FDA.[1] Market forces include rising VC interest in neurotech and diagnostics, plus public-private partnerships for economic impact via innovation clusters.[1] LBV influences the ecosystem by enabling pre-revenue startups to achieve launch readiness, fostering alliances that amplify tech transfer from academia (e.g., Rutgers, Penn State) to commercial ventures.[1]
LBV is positioned to expand as health tech demands grow, potentially deepening AI-regulatory tools and international venturing amid biotech funding rebounds. Trends like personalized medicine and digital therapeutics will shape its path, with its network enabling influence in startup acceleration. As a bridge for VC-backed innovation, LBV's de-risking focus could evolve into broader impact, scaling boutique expertise to more global clusters—tying back to its core as a venture strategy enabler in a tech-driven health landscape.[1]
LBV has raised $100.0M in total across 1 funding round.
LBV's investors include Coral Capital.
LBV has raised $100.0M across 1 funding round. Most recently, it raised $100.0M Seed in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2021 | $100.0M Seed | Coral Capital |